Featured
New Myelofibrosis Treatments Offer Hope, Improve Quality of Life
Trial Briefs Oct 16, 2026
Drug Approvals Oct 15, 2026
Drug Approvals Oct 14, 2026
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...
Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling...
A study in Nature overturns the assumption that longer sleep is universally better for aging....
Read our latest Drug Approvals articles.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks,...
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
New myelofibrosis treatments offer hope and improve quality of life, with patient-focused strategies from the NCCN guiding management.
New myelofibrosis treatments offer hope and improve quality of life, with patient-focused strategies from the NCCN guiding management.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower hematocrit levels below 45% to...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks, involving deeper bleeding and pain.
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare blood cancer in nearly 30...
Black Americans face over double the multiple myeloma risk compared to white Americans, yet reasons remain unexplained.
Patients can effectively advocate for their polycythemia vera care needs by preparing for medical visits and communicating symptoms.
Extreme temperatures worsen symptoms for polycythemia vera patients, with itching intensifying in hot and cold weather.
A man's persistent armpit lump led to a rare breast cancer diagnosis, highlighting the importance of early detection and awareness.
Systemic mastocytosis gut symptoms often mimic other conditions, delaying diagnosis in up to 85% of patients—learn why this rare blood...
Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling fellowship and toddlers during the...